Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
strategic review
Pharma
Eisai telegraphs 121 layoffs in US amid new restructuring drive
As Eisai banks on a potential growth surge for its Alzheimer’s med Leqembi, the Japanese drugmaker is reworking parts of its operations in the U.S.
Fraiser Kansteiner
Feb 27, 2025 2:16pm
Scilex Holding mulls spinoff, IPO for Scilex Pharma
Oct 16, 2024 11:20am
EuroAPI taps new CEO as it embarks on restructuring campaign
Feb 28, 2024 3:40pm
Novartis launches strategic review of India outfit
Feb 16, 2024 3:14pm
Amid strategic review, EuroAPI parts ways with CEO
Oct 25, 2023 4:37pm
Danaher to buy antibody expert Abcam for $5.7B
Aug 28, 2023 9:18am
